ANTICHOLINERGIC TOXICITY

Clinical trials for ANTICHOLINERGIC TOXICITY explained in plain language.

Never miss a new study

Get alerted when new ANTICHOLINERGIC TOXICITY trials appear

Sign up with your email to follow new studies for ANTICHOLINERGIC TOXICITY, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1 Not yet finished but already full! 1

Could a common Alzheimer's drug tame Poison-Induced delirium?

Symptom relief Terminated

This study tests whether rivastigmine, a drug used for Alzheimer's, can help people with severe confusion and agitation caused by poisoning from certain medications. About 42 participants aged 10 and older will receive either rivastigmine or a placebo. The goal is to see if rivas…

Matched conditions: ANTICHOLINERGIC TOXICITY

Phase: PHASE2 • Sponsor: Washington University School of Medicine • Aim: Symptom relief

Last updated May 17, 2026 02:53 UTC

ANTICHOLINERGIC TOXICITY

Get alerted when new ANTICHOLINERGIC TOXICITY trials appear

Could a common Alzheimer's drug tame Poison-Induced delirium?